Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights
Summary
This trial is testing a new way to do a nerve block that may minimize the amount of pain medication needed post-operatively.
Eligible Conditions
- Postoperative Pain
- Hip Replacement
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Measurement of opioid use
Secondary outcome measures
Measurement of the pain control
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CMPExperimental Treatment1 Intervention
Cluneal nerve Block 0.25% bupivacaine 20ml Pericapsular Nerve group block 0.25% Bupivacaine 20ml Lateral femoral cutaneous Block 0.25% bupivacaine 10ml
Group II: Fascia iliacaActive Control1 Intervention
Fascia iliaca block suprainguinal technique 0.25% bupivacaine 50ml
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CMP
2008
N/A
~20
Find a Location
Who is running the clinical trial?
Loyola UniversityLead Sponsor
156 Previous Clinical Trials
31,061 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger